Annette North, EVP, General Counsel & Secty at Turning Point Therapeutics, Inc. (TPTX), sold 38,800 shares at $103.30 ($4.3M) on 2021-03-08, disclosed to the SEC on 2021-03-09.
Open-market sale of $4.3M TPTX by EVP, General Counsel & Secty. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.30 | 500 | $52K | 1.2% |
| 2 | $109.09 | 4,810 | $525K | 12.3% |
| 3 | $109.09 | 4,810 | $525K | 12.3% |
| 4 | $109.89 | 9,419 | $1.0M | 24.3% |
| 5 | $109.89 | 9,419 | $1.0M | 24.3% |
| 6 | $110.77 | 4,571 |
| $506K |
| 11.9% |
| 7 | $110.77 | 4,571 | $506K | 11.9% |
| 8 | $111.69 | 700 | $78K | 1.8% |
| Total | $109.85 avg | 38,800 | $4.3M | 100% |
| Filing → |
| TPTX | SELL | 2021-06-16 | $2.1M | — | Filing → |
| TPTX | SELL | 2021-02-02 | $5.7M | — | Filing → |